BBH — VanEck Biotech ETF price, holdings and performance

VanEck Biotech ETF

VanEck Biotech ETF (NASDAQ: BBH) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
234.14
-2.58-1.09%
OverviewShort InterestFilings
BBHVanEck Biotech ETF·NASDAQ
234.14-1.09%
TA
Loading chart...
Screen all →
VXUS-0.72%$85.88VUG+0.36%$88.75VTV-0.24%$221.25VO-0.19%$80.00VB-0.45%$289.61VWO+0.17%$60.01VGT+0.68%$122.31VIG-0.05%$237.00
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y40.46%Total Holdings25Perf Week2.07%
SponsorVanEckETF TypeTagssectorReturn% 3Y13.91%AUM$458.69MPerf Month-4.05%
Fund FamilyBond TypeTags-Return% 5Y2.48%NAV/shPerf Quarter24.78%
Index-Average MaturityTags-Return% 10Y52W High244.35 -4.18%Perf Half Y27.06%
Index WeightingCommodity TypeTags-Return% SI52W Low160.91 45.51%Perf YTD23.71%
Active/PassiveQuant TypeTags-Flows% 1M0.00%Volatility0.75% 0.98%Perf Year41.33%
Dividend TTM0.96 (0.41%)ESG TypeTags-Flows% 3M-1.88%ATR (14)3.51Perf 3Y45.44%
Dividend Ex-DateDec 22, 2025Dividend TypeSector/ThemeFlows% YTD0.22%RSI (14)54.47Perf 5Y8.09%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.68Perf 10Y101.32%
Expense0.35%Growth/ValueSMA20-1.13%Flows% 3YRel Volume0.33Prev Close236.72
Inverse/LeveragedMarket CapSMA505.56%Flows% 5YAvg Volume7.72KPrice234.14
IPO DateDec 20, 2011Option/ShortYes / YesSMA20017.69%52W Range %88%Volume2,517Change-1.09%
Assets Under Management
0150.00M300.00M450.00M600.00MFebMayJulSepNov'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Sep-18-26
Sep-18-2605:22AM
5 Undervalued Oncology Stocks Wall Street Is OverlookingSeekingAlpha
Sep-16-26
Sep-16-2603:21AM
Should You Invest in the VanEck Biotech ETF (BBH)?zacks.com
Sep-15-26
Sep-15-2602:44PM
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?fool.com
Sep-03-26
Sep-03-2608:05AM
The Market May Be Telling Us We're Entering A Capital Formation CycleSeekingAlpha
Aug-24-26
Aug-24-2606:55AM
Where Is Growth?SeekingAlpha
04:40AM
BBH: Biotech's Next Growth Cycle Is Just Getting Startedseekingalpha.com
Aug-20-26
Aug-20-2601:14PM
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?fool.com
Aug-19-26
Aug-19-2605:10PM
Healthy And Energized At New HighsSeekingAlpha
Aug-12-26
Aug-12-2603:15AM
How Do You Invest In The AI Value Chain?SeekingAlpha
Aug-06-26
Aug-06-2609:20PM
Health Care Shakes Off A 5-Day SlideSeekingAlpha
Aug-05-26
Aug-05-2611:02AM
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026?fool.com
Jul-29-26
Jul-29-2607:58PM
Health Care's Clean Bill Of BreadthSeekingAlpha
Jul-25-26
Jul-25-2604:25AM
Healthcare Systems' Liquidity ChallengeSeekingAlpha
Jul-21-26
Jul-21-2611:35PM
The Steepener Was Built On A Barrel Of OilSeekingAlpha
Jul-19-26
Jul-19-2602:27AM
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?fool.com
Fund

The VanEck Biotech ETF (BBH) aims to closely reflect the price appreciation and income yield of the MVIS US Listed Biotech 25 Index (MVBBHTR), prior to the deduction of fees and expenses. This index monitors the aggregate performance of corporations involved in the research, manufacturing, promotion, and sale of medications derived from genetic insights and diagnostic technologies.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR